155 related articles for article (PubMed ID: 34249282)
21. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
Chai G; Li L; Zhou W; Wu L; Zhao Y; Wang D; Lu S; Yu Y; Wang H; McNutt MA; Hu YG; Chen Y; Yang Y; Wu X; Otterson GA; Zhu WG
PLoS One; 2008 Jun; 3(6):e2445. PubMed ID: 18560576
[TBL] [Abstract][Full Text] [Related]
22. Effect of valproic acid and zebularine on SOCS-1 and SOCS-3 gene expression in colon carcinoma SW48 cell line.
Sanaei M; Kavoosi F; Behjoo H
Exp Oncol; 2020 Sep; 42(3):183-187. PubMed ID: 32996734
[TBL] [Abstract][Full Text] [Related]
23. Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma.
Sanaei M; Kavoosi F; Safarzadeh M
Gastroenterol Hepatol Bed Bench; 2022; 15(1):39-44. PubMed ID: 35611249
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.
Xiong H; Qiu H; Zhuang L; Xiong H; Jiang R; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):498-502. PubMed ID: 19662370
[TBL] [Abstract][Full Text] [Related]
25. Sodium valproate and 5-aza-2'-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells.
Rocha MA; Veronezi GMB; Felisbino MB; Gatti MSV; Tamashiro WMSC; Mello MLS
Sci Rep; 2019 Dec; 9(1):18236. PubMed ID: 31796828
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.
Mongan NP; Gudas LJ
Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557
[TBL] [Abstract][Full Text] [Related]
27. 5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene.
Liu R; Zhang XH; Zhang K; Li W; Wang WJ; Luo DX; Gao L
Int J Ophthalmol; 2014; 7(1):51-6. PubMed ID: 24634863
[TBL] [Abstract][Full Text] [Related]
28. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.
Zhu WG; Otterson GA
Curr Med Chem Anticancer Agents; 2003 May; 3(3):187-99. PubMed ID: 12769777
[TBL] [Abstract][Full Text] [Related]
29. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
Bovenzi V; Momparler RL
Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.
Miasaki FY; Vivaldi A; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
J Endocrinol Invest; 2008 Aug; 31(8):724-30. PubMed ID: 18852534
[TBL] [Abstract][Full Text] [Related]
32. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
33. 5-Aza-2<-deoxycytidine induces hepatoma cell apoptosis via enhancing methionine adenosyltransferase 1A expression and inducing S-adenosylmethionine production.
Liu WJ; Ren JG; Li T; Yu GZ; Zhang J; Li CS; Liu ZS; Liu QY
Asian Pac J Cancer Prev; 2013; 14(11):6433-8. PubMed ID: 24377546
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
35. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
Hurtubise A; Momparler RL
Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
[TBL] [Abstract][Full Text] [Related]
36. [Effect of 5-aza-2'-deoxycytidine on cell of high-risk patients with myelodysplastic syndrome in vitro].
Tong HY; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):467-71. PubMed ID: 15363133
[TBL] [Abstract][Full Text] [Related]
37. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
Mirza S; Sharma G; Pandya P; Ralhan R
Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
[TBL] [Abstract][Full Text] [Related]
38. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene.
Zhang B; Huang T; Liu K; Chen J; Wang G
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):543-6. PubMed ID: 18060631
[TBL] [Abstract][Full Text] [Related]
40. [5-aza-2'-deoxycytidine-induced inhibition of CDH13 expression and its inhibitory effect on methylation status in human colon cancer cells in vitro and on growth of xenograft in nude mice].
Ren JZ; Huo JR
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):6-10. PubMed ID: 22490847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]